9/4/26 16:22 | 9/3/26 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -16 | 3.04 | 0 | -5 | -2 | 243 | D | | | | | | | | | | | | | | |
6/5/26 16:33 | 6/3/26 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -42 | 2.70 | 0 | -15 | -6 | 248 | D | | | | | | | | | | | | | | |
3/4/26 16:56 | 3/3/26 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -11 | 2.02 | 0 | -5 | -2 | 264 | D | | | | | | | | | | | | | | |
12/4/25 16:38 | 12/3/25 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -12 | 2.15 | 0 | -6 | -2 | 269 | D | | | | | | | | | | | | | | |
9/4/25 16:20 | 9/3/25 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -15 | 2.60 | 0 | -6 | -2 | 275 | D | | | | | | | | | | | | | | |
6/4/25 18:36 | 6/3/25 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -26 | 1.72 | 0 | -15 | -5 | 280 | D | | | | | | | | | | | | | | |
3/5/25 16:43 | 3/4/25 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -28 | 1.71 | 0 | -17 | -5 | 295 | D | | | | | | | | | | | | | | |
12/5/24 16:40 | 12/3/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -3 | 2.08 | 0 | -2 | -1 | 312 | D | | | | | | | | | | | | | | |
9/6/24 16:18 | 9/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -5 | 3.42 | 0 | -2 | 0 | 314 | D | | | | | | | | | | | | | | |
6/6/24 16:17 | 6/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -67 | 5.50 | 0 | -12 | -4 | 315 | D | | | | | | | | | | | | | | |
3/5/24 20:00 | 3/5/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S.d | -733 | 9.42 | 0 | -78 | -19 | 327 | D | | | | | | | | | | | | | | |
6/7/23 16:30 | 6/5/23 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -62 | 9.50 | 0 | -6 | -5 | 130 | D | | | | | | | | | | | | | | |
5/24/19 20:07 | 5/23/19 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Neill Gilmore Neil | MA | O | EVP,R,D, | M.d | 0 | 0.00 | 0 | 12 | | 7 | D | | | | | | | | | | | | | | |